10 results on '"Revilla-Montag, Alejandro"'
Search Results
2. Refractory Thrombocytopenia Responds to Octreotide Treatment in a Case of Evans Syndrome with Gastric Neuroendocrine Tumor
- Author
-
Chung-Delgado, Kocfa, Revilla-Montag, Alejandro, Guillén-Bravo, Sonia, Ríos-Díaz, Hugo, and Alva-Muñoz, José C.
- Subjects
Article Subject - Abstract
A 37-year-old woman with history of Evans Syndrome with poor response to high-dose corticoid treatment presented to the emergency department with gastrointestinal and vaginal bleeding. The patient was later diagnosed with severe thrombocytopenia and a stage G1, well-differentiated gastric neuroendocrine tumor, confirmed by a biopsy. A total gastrectomy was performed to eradicate the tumor. After being treated with a total splenectomy for her Evans Syndrome with no clinical or laboratory improvement, she began regular treatment with octreotide on the basis of a possible hepatic metastasis. Days after the initiation of the octreotide, an increase in the platelet count was evidenced by laboratory findings, from 2,000 platelets/mm3 to 109,000 platelets/mm3. Weeks later, the hepatic metastasis is discarded by a negative octreotide-body scan, and the octreotide treatment was interrupted. Immediately after the drug interruption, a progressive and evident descent in the platelet count was evidenced (4000 platelets/mm3). The present case report highlights the possible association between octreotide treatment and a severe thrombocytopenia resistant to conventional treatment.
- Published
- 2013
- Full Text
- View/download PDF
3. Mortality among MDR-TB Cases: Comparison with Drug-Susceptible Tuberculosis and Associated Factors
- Author
-
Chung-Delgado, Kocfa, primary, Guillen-Bravo, Sonia, additional, Revilla-Montag, Alejandro, additional, and Bernabe-Ortiz, Antonio, additional
- Published
- 2015
- Full Text
- View/download PDF
4. Factors Associated with Anti-Tuberculosis Medication Adverse Effects: A Case-Control Study in Lima, Peru
- Author
-
Chung Delgado, Kocfa, Revilla Montag, Alejandro, Guillen Bravo, Sonia, Velez Segovia, Eduardo, Soria Montoya, Andrea, Nuñez Garbin, Alexandra, Silva-Caso, Wilmer, Bernabe-Ortiz, Antonio, Chung Delgado, Kocfa, Revilla Montag, Alejandro, Guillen Bravo, Sonia, Velez Segovia, Eduardo, Soria Montoya, Andrea, Nuñez Garbin, Alexandra, Silva-Caso, Wilmer, and Bernabe-Ortiz, Antonio
- Abstract
Background: Long-term exposure to anti-tuberculosis medication increases risk of adverse drug reactions and toxicity. The objective of this investigation was to determine factors associated with anti-tuberculosis adverse drug reactions in Lima, Peru, with special emphasis on MDR-TB medication, HIV infection, diabetes, age and tobacco use. Methodology and Results: A case-control study was performed using information from Peruvian TB Programme. A case was defined as having reported an anti-TB adverse drug reaction during 2005–2010 with appropriate notification on clinical records. Controls were defined as not having reported a side effect, receiving anti-TB therapy during the same time that the case had appeared. Crude, and age- and sex-adjusted models were calculated using odds ratios (OR) and 95% confidence intervals (95%CI). A multivariable model was created to look for independent factors associated with side effect from anti-TB therapy. A total of 720 patients (144 cases and 576 controls) were analyzed. In our multivariable model, age, especially those over 40 years (OR = 3.93; 95%CI: 1.65–9.35), overweight/obesity (OR = 2.13; 95%CI: 1.17–3.89), anemia (OR = 2.10; IC95%: 1.13–3.92), MDR-TB medication (OR = 11.1; 95%CI: 6.29–19.6), and smoking (OR = 2.00; 95%CI: 1.03–3.87) were independently associated with adverse drug reactions. Conclusions: Old age, anemia, MDR-TB medication, overweight/obesity status, and smoking history are independent risk factors associated with anti-tuberculosis adverse drug reactions. Patients with these risk factors should be monitored during the anti-TB therapy. A comprehensive clinical history and additional medical exams, including hematocrit and HIV-ELISA, might be useful to identify these patients., Revisión por pares
- Published
- 2014
5. Refractory Thrombocytopenia Responds to Octreotide Treatment in a Case of Evans Syndrome with Gastric Neuroendocrine Tumor
- Author
-
Chung Delgado, Kocfa, Revilla Montag, Alejandro, Guillén Bravo, Sonia, Ríos Díaz, Hugo, Alva Muñoz, José C., Chung Delgado, Kocfa, Revilla Montag, Alejandro, Guillén Bravo, Sonia, Ríos Díaz, Hugo, and Alva Muñoz, José C.
- Abstract
A 37-year-old woman with history of Evans Syndrome with poor response to high-dose corticoid treatment presented to the emergency department with gastrointestinal and vaginal bleeding. The patient was later diagnosed with severe thrombocytopenia and a stage G1, well-differentiated gastric neuroendocrine tumor, confirmed by a biopsy. A total gastrectomy was performed to eradicate the tumor. After being treated with a total splenectomy for her Evans Syndrome with no clinical or laboratory improvement, she began regular treatment with octreotide on the basis of a possible hepatic metastasis. Days after the initiation of the octreotide, an increase in the platelet count was evidenced by laboratory findings, from 2,000 platelets/mm3 to 109,000 platelets/mm3 . Weeks later, the hepatic metastasis is discarded by a negative octreotide-body scan, and the octreotide treatment was interrupted. Immediately after the drug interruption, a progressive and evident descent in the platelet count was evidenced (4000 platelets/mm3 ). The present case report highlights the possible association between octreotide treatment and a severe thrombocytopenia resistant to conventional treatment., Revisión por pares
- Published
- 2014
6. Estudiantes de medicina en riesgo:prevalencia e incidencia de conversión de PPD
- Author
-
Chung Delgado, Kocfa, Guillén Bravo, Sonia, Navarro Huamán, Laura, Quiroz Portella, Rafael, Revilla Montag, Alejandro, Ruíz Alejos, Andrea, Zapata Pachas, Mariana, Bernabe-Ortiz, Antonio, Chung Delgado, Kocfa, Guillén Bravo, Sonia, Navarro Huamán, Laura, Quiroz Portella, Rafael, Revilla Montag, Alejandro, Ruíz Alejos, Andrea, Zapata Pachas, Mariana, and Bernabe-Ortiz, Antonio
- Abstract
Introducción: Un tercio de la población mundial presenta una infección tuberculosa latente, con 9,4 millones de casos nuevos reportados en el 2009; los estudiantes de medicina tienen de 2 a 50 veces más probabilidad de adquirir la infección. Objetivos: Establecer la prevalencia de PPD positivo basal al inicio de la carrera médica y determinar la incidencia y los factores asociados a la conversión de PPD en alumnos de medicina. Materiales y Métodos: Análisis secundario de datos de una cohorte histórica (2007-2010) involucrando alumnos de medicina de una universidad privada en Perú. Se evaluó la conversión de PPD. Se aplicó un análisis de regresión binomial para cada variable de interés. Resultados: 707 estudiantes fueron seguidos, de ellos 219 (31%) fueron hombres. La prevalencia basal de PPD positivo fue 14,4%. Se encontró asociación significativa con el año de ingreso 2007-08 (p = 0,007) y antecedente de tuberculosis anterior (p = 0,02). Con un total de 822 personas-año, la incidencia de conversión fue de 2,92 por 100 personas-año (IC95%: 1,96-4,36). En el modelo bivariado, el año de ingreso a la carrera y el IMC > 25 kg/m2 estuvieron asociados con conversión de PPD. Sin embargo, en el modelo multivariado, sólo el año de ingreso mostró asociación estadísticamente significativa (RR = 2,53; IC95%: 1,11-5,76). Conclusiones: Existe una prevalencia basal elevada de infección latente en alumnos de medicina. La tasa de incidencia está dentro de los valores esperados y previamente reportados. Se recomienda prestar más atención a las medidas de bioseguridad y prevención en estudiantes de medicina., Revisión por pares
- Published
- 2014
7. Estudiantes de medicina en riesgo: prevalencia e incidencia de conversión de PPD
- Author
-
Chung-Delgado, Kocfa, primary, Guillén-Bravo, Sonia, additional, Navarro-Huamán, Laura, additional, Quiroz-Portella, Rafael, additional, Revilla-Montag, Alejandro, additional, Ruíz-Alejos, Andrea, additional, Zapata-Pachas, Mariana, additional, and Bernabé-Ortiz, Antonio, additional
- Published
- 2012
- Full Text
- View/download PDF
8. Factors Associated with Anti-Tuberculosis Medication Adverse Effects: A Case-Control Study in Lima, Peru
- Author
-
Chung-Delgado, Kocfa, primary, Revilla-Montag, Alejandro, additional, Guillen-Bravo, Sonia, additional, Velez-Segovia, Eduardo, additional, Soria-Montoya, Andrea, additional, Nuñez-Garbin, Alexandra, additional, Silva-Caso, Wilmer, additional, and Bernabe-Ortiz, Antonio, additional
- Published
- 2011
- Full Text
- View/download PDF
9. Factors Associated with Anti-Tuberculosis Medication Adverse Effects: A Case-Control Study in Lima, Peru.
- Author
-
Kocfa Chung-Delgado, Revilla-Montag, Alejandro, Guillen-Bravo, Sonia, Segovia, Eduardo Velez-, Soria-Montoya, Andrea, Nuñez-Garbin, Alexandra, Silva-Caso, Wilmer, and Bernabe-Ortiz, Antonio
- Subjects
- *
TUBERCULOSIS , *DRUGS , *DIABETES , *OBESITY - Abstract
Background: Long-term exposure to anti-tuberculosis medication increases risk of adverse drug reactions and toxicity. The objective of this investigation was to determine factors associated with anti-tuberculosis adverse drug reactions in Lima, Peru, with special emphasis on MDR-TB medication, HIV infection, diabetes, age and tobacco use. Methodology and Results: A case-control study was performed using information from Peruvian TB Programme. A case was defined as having reported an anti-TB adverse drug reaction during 2005-2010 with appropriate notification on clinical records. Controls were defined as not having reported a side effect, receiving anti-TB therapy during the same time that the case had appeared. Crude, and age- and sex-adjusted models were calculated using odds ratios (OR) and 95% confidence intervals (95%CI). A multivariable model was created to look for independent factors associated with side effect from anti-TB therapy. A total of 720 patients (144 cases and 576 controls) were analyzed. In our multivariable model, age, especially those over 40 years (OR = 3.93; 95%CI: 1.65-9.35), overweight/obesity (OR = 2.13; 95%CI: 1.17-3.89), anemia (OR = 2.10; IC95%: 1.13-3.92), MDR-TB medication (OR = 11.1; 95%CI: 6.29-19.6), and smoking (OR = 2.00; 95%CI: 1.03-3.87) were independently associated with adverse drug reactions. Conclusions: Old age, anemia, MDR-TB medication, overweight/obesity status, and smoking history are independent risk factors associated with anti-tuberculosis adverse drug reactions. Patients with these risk factors should be monitored during the anti-TB therapy. A comprehensive clinical history and additional medical exams, including hematocrit and HIV-ELISA, might be useful to identify these patients. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
10. [Medical students at risk: prevalence and incidence of tuberculin skin test conversion].
- Author
-
Chung-Delgado K, Guillén-Bravo S, Navarro-Huamán L, Quiroz-Portella R, Revilla-Montag A, Ruíz-Alejos A, Zapata-Pachas M, and Bernabé-Ortiz A
- Subjects
- Female, Humans, Incidence, Latent Tuberculosis diagnosis, Male, Peru epidemiology, Prevalence, Retrospective Studies, Risk, Risk Factors, Schools, Medical, Latent Tuberculosis epidemiology, Students, Medical statistics & numerical data, Tuberculin Test
- Abstract
Introduction: One third of the world population is affected by latent tuberculosis, with 9.4 million new cases; medical students have 2 to 50 times the probability of acquiring the infection., Objectives: Establish the baseline prevalence of positive tuberculin skin test (TST) at the beginning of medical studies and determine the incidence and variables associated with TST conversion in medical students., Materials and Methods: Secondary analysis of a historical cohort (2007-2010) of medical students in a private Peruvian university. The TST conversion was evaluated. A binomial regression analysis was applied for each associated variable., Results: 707 medical students were included, of whom 219 (31%) were male. The basal prevalence of reactive TST was 14.4%. Significant associations were found with the year of university entry of 2007-08 (p = 0.007) and a history of tuberculosis (p = 0.02). With a total of 822 person-years, the incidence of conversion was 2.92 cases per 100 person-years (CI95%: 1.96-4.36). The TST conversion was associated with the year of university entry (RR = 2,55; IC95%: 1,06-6,30) and a body mass index > 25 kg/m² (RR = 0,16; IC95%: 0,01-0,97). No association was detected with gender, tobacco or alcohol use., Conclusions: There is evidence of a high basal prevalence of latent tuberculosis infection in medical students. The incidence rate is within expected values and high in comparison with the general population. People with BMI > 25 kg/m² have protection against a latent infection. In medical students, more attention should be paid to biosecurity.
- Published
- 2012
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.